PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-Jun-2022 Spine Implants Global Market Report 2022: A $15.77 Billion Market in 2026 - Forecast to 2031 - ResearchAndMarkets.com Businesswire
10-Jun-2022 Healthcare Projects included in 50 Most Inspiring Projects of the Past 50 Years Association for Project Management
10-Jun-2022 ADC Therapeutics Announces Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma Businesswire
10-Jun-2022 MEI Pharma and Kyowa Kirin Report Clinical Data on Zandelisib at European Hematology Association 2022 Hybrid Congress Businesswire
10-Jun-2022 Advicenne Provides an Update on Its Activities Following Its Annual General Meeting and Board of Directors Meeting on June 9, 2022 Businesswire
10-Jun-2022 Genentech Announces Positive Data from Broad Blood Cancer Portfolio at European Hematology Association Annual Meeting Businesswire
10-Jun-2022 Vacina da Takeda fornece proteção contínua contra a dengue por 4,5 anos em ensaio clínico pivotal Businesswire
10-Jun-2022 Arthritis National Research Foundation Announces 2022-23 Grant Recipients Businesswire
10-Jun-2022 Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute Businesswire
09-Jun-2022 La vacuna candidata de Takeda contra el dengue ofrece protección contra esta enfermedad durante cuatro años y medio en un ensayo clínico fundamental Businesswire
09-Jun-2022 Healthcare Is Personal: GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health & Theranostics for Personalized Prostate Cancer Care Businesswire
09-Jun-2022 NANOBIOTIX: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital Businesswire
09-Jun-2022 With New Funding, Phase Genomics Seeks to Eliminate One of Biology’s Biggest Blind Spots Businesswire
09-Jun-2022 Dengue-Impfstoffkandidat von Takeda bietet einer zulassungsrelevanten klinischen Studie zufolge 4,5 Jahre lang Schutz vor Dengue-Fieber Businesswire
09-Jun-2022 EUROAPI joins the SBF 120 and CAC Mid 60 indices Businesswire
09-Jun-2022 Le vaccin candidat de Takeda contre la dengue a apporté une protection continue contre la dengue durant un essai clinique pivot de 4,5 ans Businesswire
09-Jun-2022 Dr. Kiana Aran and Dr. Paul Grint appointed to CRISPR QC Board of Directors Businesswire
09-Jun-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Anaplan, Inc. (PLAN) on Behalf of Investors Businesswire
09-Jun-2022 The Worldwide Pharmacovigilance Industry is Expected to Reach $15.8 Billion by 2030 - ResearchAndMarkets.com Businesswire
09-Jun-2022 Advicenne: Share-Purchase Program Authorized by the Annual General Meeting of June 9, 2022 Businesswire